Trial
NCT01754623
GTX-RT in Borderline Resectable Pancreatic Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
—
Condition
Pancreatic Cancer
Intervention
Capecitabine
Why stopped
Lack of pre-treatment tissue to make the study plan feasible.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-08-13